-
Start Preamble
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the National Advisory Neurological Disorders and Stroke Council.
The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.
Name of Committee: National Advisory Neurological Disorders and Stroke Council, Basic and Preclinical Programs Subcommittee.
Date: February 3, 2011.
Time: 8 a.m. to 10 a.m.
Agenda: To discuss basic and preclinical programs policy.
Place: National Institutes of Health, Building 31, 31 Center Drive, Conference Room #7, Bethesda, MD 20892.
Contact Person: William D. Matthew, MD, Director, Office of Translational Research, NINDS, National Institutes of Health, 6001 Executive Blvd., Room 2137, Bethesda, MD 20892. 301-496-1779. bill.matthew@nih.gov.
In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver's license, or passport) and to state the purpose of their visit.
Information is also available on the Institute's/Center's home page: http://www.ninds.nih.gov,, where and agenda and any additional information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS)
Start SignatureDated: January 5, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-579 Filed 1-11-11; 8:45 am]
BILLING CODE 4140-01-P
Document Information
- Effective Date:
- 2/3/2011
- Published:
- 01/12/2011
- Department:
- National Institutes of Health
- Entry Type:
- Notice
- Document Number:
- 2011-579
- Dates:
- February 3, 2011.
- Pages:
- 2129-2129 (1 pages)
- PDF File:
- 2011-579.pdf
- Supporting Documents:
- » License Agreements; Start-Up Exclusive Evaluation Option: Activators of Human Pyruvate Kinase to Treat Cancer
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: National Institute of Nursing Research
- » Meetings: National Institute of Allergy and Infectious Diseases
- » Meetings: National Eye Institute
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: Center for Scientific Review
- » Meetings: Center for Scientific Review
- » Meetings: National Institute of Environmental Health Sciences
- » Meetings: National Human Genome Research Institute